A placebo- and active-controlled (ciclesonide metered-dose inhaler), randomized, parallel-group, dose-range finding study of ciclesonide administered by dry powder inhaler (Ultrahaler) in adult and adolescent patients with persistent asthma.
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2009
At a glance
- Drugs Ciclesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Sanofi
- 07 Jul 2009 Planned number of patients changed from 1146 to 1145 as reported by ClinicalTrials.gov.
- 31 Dec 2005 New trial record.